Keshava Organics is an API manufacturer based in India. It holds 5 active US drug master files across a filed portfolio of 5 molecules. Its most recent recorded inspection, by US FDA, closed on 13 January 2023 as VAI. Customs aggregates show $7.6M of exports covering 149 molecules to 26 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Palghar, India | 3003677831 |
| Molecule | Regulators | Docs |
|---|---|---|
| Chlorpheniramine | SFDA (Saudi Arabia), US FDA | 2 |
| Brompheniramine | US FDA | 1 |
| Dexchlorpheniramine | US FDA | 1 |
| Mepyramine | US FDA | 1 |
| Pheniramine | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.1M | 18 |
| 2025 | Not reported | $7.6M | 26 |
| 2024 | Not reported | $6.7M | 25 |
| 2023 | Not reported | $5.5M | 25 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Keshava Organics comes back tiered against every other supplier able to file there.
Start for free